{
    "Trade/Device Name(s)": [
        "CLINIQA Liquid QC\u2122 Bilirubin Controls Levels 1, 2 & 3",
        "CLINIQA LiniCAL\u2122 Bilirubin Calibration Verifiers Levels A-E for Olympus AU Systems\u2122"
    ],
    "Submitter Information": "Cliniqa Corporation",
    "510(k) Number": "K052679",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "November 18, 2005",
    "Summary Letter Received Date": "September 28, 2005",
    "Submission Date": "September 26, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Bilirubin",
        "Direct Bilirubin"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Olympus AU Systems\u2122"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Calibration verifier"
    ],
    "Document Summary": "FDA 510(k) summary for CLINIQA Liquid QC Bilirubin Controls and LiniCAL Bilirubin Calibration Verifiers for Olympus AU Systems as assayed quality control materials.",
    "Indications for Use Summary": "Intended as assayed quality control materials to provide levels of Total and Direct Bilirubin and to evaluate performance of Olympus AU Systems at various concentrations.",
    "fda_folder": "Clinical Chemistry"
}